	Nutritional Therapy in Pancreatic Cancer: Mechanisms, Clinical Applications, and Future Perspectives. Nutr Cancer Okabayashi T, Tabuchi M, Tokumaru T, Uemura S, Tamura S. PMID: 42411702 [PubMed - as supplied by publisher]
	Integrative single-cell and spatial transcriptomic approaches to decipher the tumor microenvironment and therapeutic resistance in pancreatic cancer. Cancer Biol Ther Luo M, Shen F, Xu W, Corpe C, Wang J. PMID: 42411636 [PubMed - in process]
	Liquid biopsy-based multi-omics approach for early detection of hepatocellular carcinoma (ASCEND-Hep): a multiphase prospective development and validation study. BMC Med Wang C, Cai L, Yang Y, Wang W, Zhao K, Xie W, Zhou Q, Zhang Q, Zhang C, Deng M, Bao S, Bi J, Chen X, Xie H, Fu S, He G, Cheng Y, Zhong K, Wen Y, Xu Y, Duan F, Liu F, Shi Y, Yao J, Xu J, Zhao J, Zhang Y, Wang G, Han Y, Yang T, Cai S, He J, Pan M. PMID: 42410425 [PubMed - as supplied by publisher]
	Laparoscopic versus open pancreaticoduodenectomy for non-pancreatic periampullary adenocarcinomas: study protocol for a multicentre randomised controlled trial in China. BMJ Open Li S, Pan S, Wang M, Huang X, Zhao W, Yu X, Chen X, Chen H, Dang X, Chen G, Wang L, An W, Zhang Q, Gao S, Guo S, Qin T, Zhang H, Qin R. PMID: 42409398 [PubMed - indexed for MEDLINE]
	Ivonescimab plus gemcitabine and cisplatin as first-line therapy for advanced biliary tract cancer: a multicenter, open-label phase 2 trial. J Hepatol Xu Q, Zhou S, Zhang C, Zhou Y, He Y, Jiang Y, Li J, Yi T, Luo C, Zhang L, Wu J, Zhang Y, Wu M, Wei Q, Li Q, Liu B, Chen X, Yao Y, Yu C, Li J, Ren Y, Zhuo W, Yuan L, Li W, Wang ZM, Li B, Xia M, Xie Y, Wu K, Ying J. PMID: 42409321 [PubMed - as supplied by publisher]
	Real-World Mapping of Multiple Primary Carcinoma Combinations and Survival Outcomes in Shanghai, China: Retrospective Registry-Based Study. JMIR Public Health Surveill Shi J, Chen Y, Chen C, Li X, Jin H. PMID: 42407055 [PubMed - in process]
	Reverse-Bevel (ProCore) EUS-Guided Fine-Needle Biopsy for Solid Pancreatic Mass Lesions: a GRADE-Assessed Systematic Review and Meta-Analysis of Prospective Randomized Trials. J Gastrointest Cancer Mirza W, Badshah MB, Gastroenterologist I, Hadhoud AM, Moeen-Ud-Din MB, Imtiaz A. PMID: 42406286 [PubMed - indexed for MEDLINE]
	The forgotten burden: nutrition impact symptoms in colorectal cancer survivorship. Curr Opin Support Palliat Care Furness K, Solheim-Hustad K, Kaasa S. PMID: 42405505 [PubMed - as supplied by publisher]
	Intratumoral microbiome: a key regulator and novel therapeutic target for chemoresistance in pancreatic cancer. Front Cell Infect Microbiol Wang Y, Wu J. PMID: 42404769 [PubMed - indexed for MEDLINE]
	Preoperative nutritional status, frailty, and postoperative delirium in patients undergoing pancreatic cancer surgery: a prospective observational study. Front Nutr Xia N, Ding L, Shi N, Song Y, Pan KC. PMID: 42404151 [PubMed]
	Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study. Pain Van Diepen AE, Graus MUJE, Augustinus S, Gehrels AM, Vissers PAJ, van Gansewinkel EHE, Besselink MG, van Laarhoven HWM, Bouwense SAW, Wilmink JW, Cirkel GA, Kooreman NG, Alvarez Jimenez R, van Zundert J, Homs MYV, van Kuijk SMJ, de Vos-Geelen J, Dutch Pancreatic Cancer Group. PMID: 42402901 [PubMed - as supplied by publisher]
	Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE study. J Hepatol Oh DY, Ikeda M, Macarulla T, He AR, Park JO, Kitano M, Giordano G, Kim KP, Wirth T, Tai D, Bouattour M, Pressiani T, Dayyani F, Lamarca A, Emeribe U, Radke S, Sun P, Baur B, Vogel A. PMID: 42402265 [PubMed - as supplied by publisher]
	A primary care clinic on the frontline of early cancer detection: a retrospective observational study. BMC Prim Care Yago Y, Hojo M, Shibuya T, Tsujimoto T, Nagahara A. PMID: 42401800 [PubMed - as supplied by publisher]
	Determinants of eligibility for second-line chemotherapy following gemcitabine plus nab-paclitaxel therapy in patients with unresectable pancreatic cancer: a retrospective study. BMC Gastroenterol Ueda T, Miyagawa K, Shibata M, Mori Y, Oe S, Kajitani K, Uchihara D, Shinohara N, Ogino N, Kumei S, Honma Y, Watanabe T, Harada M. PMID: 42399778 [PubMed - as supplied by publisher]
	Anatomically constrained deep learning for clinical-grade volumetric pancreatic cancer segmentation: development, validation, and architectural benchmarking. NPJ Precis Oncol Mukherjee S, Bhinder KK, Zarrintan A, Antony A, Ammirabile A, Jadoon A, Dey S, Talukdar BJ, Yamaguchi T, Graham RP, Chari ST, Goenka AH. PMID: 42399351 [PubMed - as supplied by publisher]
	Semiannual surveillance facilitates detection of surgically treatable intraductal papillary mucinous neoplasm-derived and concomitant carcinoma: a multicenter prospective observational study. Pancreatology Ohashi Y, Maruta A, Koizumi T, Iwata S, Uemura S, Tezuka R, Iwasa Y, Okuno M, Iwata K, Mukai T, Ichikawa H, Mita N, Yoshida K, Iwashita T, Shimizu M. PMID: 42399187 [PubMed - as supplied by publisher]
	Patients with hepatitis B virus-related hepatocellular carcinoma underlying cirrhosis have higher microvascular invasion and poorer prognosis after liver resection: A multicenter study. Hepatobiliary Pancreat Dis Int Cao Y, Zhang TC, Li ZQ, Yu ZT, Hu MG, Ni QQ, Xu S, Chen X, Tan G, Wang X, Xia NX, Zhao WC, Zhang F, Lu YM, Tang YF, Hu YL, Jiang T, Lin C, Cheng SQ, Zhang XP, Liu R. PMID: 42399131 [PubMed - as supplied by publisher]
	Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study. Gut Xiang YJ, Liu ZH, Feng JK, Qin YY, Yu HM, Cheng YQ, Chen G, Wu JY, Zeng YY, Tang YF, Rao JH, Zhang FM, Yang SY, Wang GR, Ye LS, Lang R, Lin JH, Zheng YT, Mao YF, Zhou HK, Yan ML, Liang C, Ren SS, Wang K, Gong L, Xu S, Xu YF, Ni QQ, Wang K, Fan RF, Hu YL, Jiang T, Lin C, Gao QL, Wang ZQ, Lu YM, Zou WB, Wang X, Feng C, Wang ZC, Liu PJ, Wei WJ, Zhang F, Wu W, Lu HF, Huang JY, Liang X, Li JJ, Shan YF, Zhang XP, Cheng SQ, Chinese Association of Liver Cancer and Chinese Medical Doctor Association. PMID: 42399086 [PubMed - as supplied by publisher]
	The immunopharmacological role of B-cell and neutrophil-derived extracellular vesicles in pancreatic cancer: Mechanisms of inflammation, tumor progression, and potential therapeutic targets. Int Immunopharmacol Maher F, Samadi A, Sajjadi SF, Heydari S, Gross J, Azimi G. PMID: 42398175 [PubMed - as supplied by publisher]
	Pancreatic Adenocarcinoma Presented as Paraneoplastic Dermatomyositis Complicated with Rhabdomyolysis: Case Report and Review. Am J Case Rep Alsheyyab J, Al-Mahasneh HA, Al-Khalaileh SY, Hasan HA, Al-Refu K. PMID: 42397795 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 60753

Page 1 of 3038



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy